Accelerating Clinical Pharmacology Study Timelines for the Treatment of Infections Caused by Highly Pathogenic Coronaviruses Case Study

Covance was approached by a sponsor to conduct an entire COVID-19 antiviral program with their compound. The sponsor had already been in contact with regulatory authorities and was close to submitting the regulatory packages. Covance was able to implement extreme acceleration of the study startup timelines. By the end of the study, it was calculated that approximately seven months in the timeline were saved from study award to last subject last visit.